Philip Bradley, general manager at Astoriom shares why robust temperature control is essential to protect product integrity, compliance, and patient safety.
Pharmaceutical manufacturing demands precision at every step. Cold chain failures are a leading, yet preventable, cause of product loss. Active pharmaceutical ingredients (APIs), intermediates and finished medicines are made in line with Good Manufacturing Practice (GMP) guidelines to ensure safety and consistency. But quality is not determined by manufacturing alone. The way products are stored, both during production and after release, is equally critical. For Europe’s expanding portfolio of temperature-sensitive biologics, vaccines, and advanced therapies, robust cold chain control is now a regulatory and operational imperative, as cold chain failures can undo months of controlled production in a matter of hours.